| 000 -LEADER |
|---|
| fixed length control field |
07837nam a2201033 i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
6813372 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
IEEE |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20200413152907.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS |
|---|
| fixed length control field |
m eo d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr cn |||m|||a |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
121018s2012 caua foab 000 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781608452057 (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Canceled/invalid ISBN |
9781608452040 (pbk.) |
| 024 7# - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
10.2200/S00437ED1V01Y201207TIS009 |
| Source of number or code |
doi |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)812199773 |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(CaBNVSL)swl00401510 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
CaBNVSL |
| Transcribing agency |
CaBNVSL |
| Modifying agency |
CaBNVSL |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
QP114.R45 |
| Item number |
R883 2012 |
| 060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QT 37 |
| Item number |
R883c 2012 |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
612.17 |
| Edition number |
23 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Ruvinov, Emil. |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Cardiac tissue engineering |
| Medium |
[electronic resource] : |
| Remainder of title |
principles, materials, and applications / |
| Statement of responsibility, etc. |
Emil Ruvinov, Yulia Sapir, and Smadar Cohen. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
San Rafael, Calif. (1537 Fourth Street, San Rafael, CA 94901 USA) : |
| Name of publisher, distributor, etc. |
Morgan & Claypool, |
| Date of publication, distribution, etc. |
c2012. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 electronic text (xv, 184 p.) : |
| Other physical details |
ill., digital file. |
| 490 1# - SERIES STATEMENT |
|---|
| Series statement |
Synthesis lectures on tissue engineering, |
| International Standard Serial Number |
1944-0308 ; |
| Volume/sequential designation |
# 9 |
| 538 ## - SYSTEM DETAILS NOTE |
|---|
| System details note |
Mode of access: World Wide Web. |
| 538 ## - SYSTEM DETAILS NOTE |
|---|
| System details note |
System requirements: Adobe Acrobat Reader. |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Part of: Synthesis digital library of engineering and computer science. |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Series from website. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
1. Introduction -- 1.1 Cardiac tissue engineering -- 1.2 Objectives and scopes -- 1.3 Organization of the monograph -- Bibliography -- |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
2. The heart, structure, cardiovascular diseases, and regeneration -- 2.1 Introduction -- 2.2 The heart and cardiac muscle structure -- 2.3 Myocardial infarction and heart failure -- 2.4 Cardiac extracellular matrix (ECM), its function and pathological changes after MI -- 2.5 Congenital heart defects -- 2.6 Endogenous myocardial regeneration -- 2.7 Potential therapeutic targets and strategies to induce myocardial regeneration -- Bibliography -- |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
3. Cell sources for cardiac tissue engineering -- 3.1 Introduction -- 3.2 Sources for de novo cardiomyocytes for clinical applications -- 3.3 Contemporary alternatives, adult autologous stem and progenitor cells -- 3.4 Clinical trials and "paracrine effect" hypothesis of stem/progenitor cell transplantation -- 3.5 Summary and conclusions -- Bibliography -- |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
4. Biomaterials, polymers, scaffolds, and basic design criteria -- 4.1 Introduction -- 4.2 Basic biomaterial design criteria -- 4.3 Biomaterial classification -- 4.4 Basic scaffold fabrication forms -- 4.5 Summary and conclusions -- Bibliography -- |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
5. Biomaterials as vehicles for stem cell delivery and retention in the infarct -- 5.1 Introduction -- 5.2 Stem cell delivery by biomaterials -- 5.3 Clinical trials -- 5.4 Summary and conclusions -- Bibliography -- |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
6. Bioengineering of cardiac patches, in vitro -- 6.1 Introduction -- 6.2 Cardiac cell entrapment in hydrogels, engineered heart tissue (EHT) -- 6.3 Cell sheet-based cardiac tissue engineering -- 6.4 Myocardial tissue grafts created in preformed implantable scaffolds -- 6.5 Biomimetic scaffolds and integration of cell-matrix interactions -- 6.6 Micro- and nanotechnology for scaffold fabrication -- 6.7 Summary and conclusions -- Bibliography -- |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
7. Perfusion bioreactors and stimulation patterns in cardiac tissue engineering -- 7.1 Introduction -- 7.2 Bioreactor cultivation of engineered cardiac tissue -- 7.3 Inductive stimulation patterns in cardiac tissue engineering -- 7.4 Summary and conclusions -- Bibliography -- |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
8. Vascularization of cardiac patches -- 8.1 Introduction -- 8.2 Prevascularization of the patch by incorporating endothelial cells (ECS) -- 8.3 The body as a bioreactor for patch vascularization -- 8.4 Summary and conclusions -- Bibliography -- |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
9. Acellular biomaterials for cardiac repair -- 9.1 Introduction -- 9.2 Acellular implantable scaffolds for in situ tissue support -- 9.3 Decellularized ECM -- 9.4 Injectable biomaterials -- 9.5 First-in-man trial of intracoronary delivery of alginate biomaterial -- 9.6 Mechanism of biomaterial effects on cardiac repair -- 9.7 Immunomodulation of the macrophages by liposomes for infarct repair -- 9.8 Summary and conclusions -- Bibliography -- |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
10. Biomaterial-based controlled delivery of bioactive molecules for myocardial regeneration -- 10.1 Introduction -- 10.2 Evolution of bioactive material approach for myocardial regeneration -- 10.3 Bioactive molecules for myocardial regeneration and repair -- 10.4 Scaffold- and hydrogel sheet-based molecule delivery -- 10.5 Injectable systems -- 10.6 Affinity-binding alginate biomaterial for multiple growth factor delivery -- 10.7 Summary and conclusions -- Bibliography -- Authors' biographies. |
| 506 1# - RESTRICTIONS ON ACCESS NOTE |
|---|
| Terms governing access |
Abstract freely available; full-text restricted to subscribers or individual document purchasers. |
| 510 0# - CITATION/REFERENCES NOTE |
|---|
| Name of source |
Compendex |
| 510 0# - CITATION/REFERENCES NOTE |
|---|
| Name of source |
INSPEC |
| 510 0# - CITATION/REFERENCES NOTE |
|---|
| Name of source |
Google scholar |
| 510 0# - CITATION/REFERENCES NOTE |
|---|
| Name of source |
Google book search |
| 520 3# - SUMMARY, ETC. |
|---|
| Summary, etc. |
Cardiac tissue engineering aims at repairing damaged heart muscle and producing human cardiac tissues for application in drug toxicity studies. This book offers a comprehensive overview of the cardiac tissue engineering strategies, including presenting and discussing the various concepts in use, research directions and applications. Essential basic information on the major components in cardiac tissue engineering, namely cell sources and biomaterials, is firstly presented to the readers, followed by a detailed description of their implementation in different strategies, broadly divided to cellular and acellular ones. In cellular approaches, the biomaterials are used to increase cell retention after implantation or as scaffolds when bioengineering the cardiac patch, in vitro. In acellular approaches, the biomaterials are used as ECM replacement for damaged cardiac ECM after MI, or, in combination with growth factors, the biomaterials assume an additional function as a depot for prolonged factor activity for the effective recruitment of repairing cells. The book also presents technological innovations aimed to improve the quality of the cardiac patches, such as bioreactor applications, stimulation patterns and prevascularization. |
| 530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE |
|---|
| Additional physical form available note |
Also available in print. |
| 588 ## - SOURCE OF DESCRIPTION NOTE |
|---|
| Source of description note |
Title from PDF t.p. (viewed on October 18, 2012). |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Heart. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Tissue engineering. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Heart |
| General subdivision |
Diseases. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Myocardium |
| General subdivision |
Regeneration. |
| 650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Heart. |
| 650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Tissue Engineering. |
| 650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Heart Diseases. |
| 650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Myocardium. |
| 650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Regeneration. |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
affinity binding |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
alginate |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
biomaterials |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
biomimetic |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
cardiac tissue engineering |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
cardiac patches |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
cardiomyocytes |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
cell delivery |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
cell therapy |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
drug delivery |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
extracellular matrix |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
growth factors |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
heart |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
hydrogels |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
heart failure |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
immunomodulation |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
liposomes |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
myocardial infarction |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
myocardial regeneration |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
paracrine effect |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
perfusion bioreactors |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
scaffolds |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
stem cells |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
stimulation |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
vascularization |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Sapir, Yulia. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Cohen, Smadar. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| Relationship information |
Print version: |
| International Standard Book Number |
9781608452040 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
Synthesis digital library of engineering and computer science. |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
Synthesis lectures on tissue engineering ; |
| Volume/sequential designation |
# 9. |
| International Standard Serial Number |
1944-0308 |
| 856 42 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Abstract with links to resource |
| Uniform Resource Identifier |
http://ieeexplore.ieee.org/servlet/opac?bknumber=6813372 |
